Dr. Edouard AUCLIN Medical Oncologist Georges Pompidou European Hospital - Paris email@example.com Researchgate profile Latest publications Carcinoembryonic Antigen Levels and Survival in Stage III Colon Cancer: Post hoc Analysis of the MOSAIC and PETACC-8 Trials. AbstractBACKGROUND:We explored and validated the association of postoperative carcinoembryonic antigen (CEA) with... Posted by : Dr. Edouard AUCLIN, Dr. Dewi VERNEREYJournal name : Cancer Epidemiol Biomarkers Prev Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial. AbstractBACKGROUND:Adjuvant treatment for stage II colon cancer (CC) can be proposed to patients with high-risk disease.... Posted by : Dr. Dewi VERNEREY, Dr. Edouard AUCLINJournal name : Br J Cancer Low-level postoperative carcinoembryonic antigen improves survival outcomes stratification in patients with stage II colon cancer treated with standard adjuvant treatments. Letter to editor.LINK Posted by : Dr. Edouard AUCLIN, Dr. Dewi VERNEREYJournal name : European Journal of Cancer Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma AbstractBackgroundNivolumab-ipilimumab demonstrated a survival benefit over sunitinib in first-line setting for... Posted by : Dr. Guillaume MOUILLET, Dr. Edouard AUCLINJournal name : European Journal of Cancer Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 Trial. AbstractBACKGROUND:Recurrence patterns in stage III colon cancer (CC) patients according to molecular markers remain... Posted by : Dr. Edouard AUCLIN, Dr. Dewi VERNEREYJournal name : Ann Surg Oncol.